Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fortress Biotech Inc FBIO

Alternate Symbol(s):  FBIOP

Healthcare Biotechnology
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions... see more

Recent & Breaking News (NDAQ:FBIO)

Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol

GlobeNewswire October 12, 2020

Checkpoint Therapeutics Announces $20.0 Million Bought Deal Offering

GlobeNewswire September 17, 2020

Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma

GlobeNewswire September 17, 2020

Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in AL Amyloidosis

GlobeNewswire September 14, 2020

Fortress Biotech to Participate in Three September 2020 Virtual Investor Conferences

GlobeNewswire September 10, 2020

Avenue Therapeutics Announces Publication of a Review of IV Tramadol

GlobeNewswire September 9, 2020

Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

GlobeNewswire September 2, 2020

LD Micro -- 360 Companies Set to Present this Week

Accesswire August 31, 2020

Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the Treatment of X-linked Severe Combined Immunodeficiency in Previously Transplanted Patients

GlobeNewswire August 31, 2020

Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper Histidinate, for the Treatment of Menkes Disease

GlobeNewswire August 28, 2020

Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management

GlobeNewswire August 28, 2020

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

GlobeNewswire August 26, 2020

Mustang Bio to Present at the Virtual Fortress Biotech Corporate Access Summit

GlobeNewswire August 17, 2020

Mustang Bio Announces Rare Pediatric Disease Designation for MB-107 for the Treatment of X-linked Severe Combined Immunodeficiency

GlobeNewswire August 17, 2020

Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

GlobeNewswire August 14, 2020

Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley FBR on Tuesday, August 18 and Wednesday, August 19, 2020

GlobeNewswire August 12, 2020

Mustang Bio Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

GlobeNewswire August 10, 2020

Fortress Biotech Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

GlobeNewswire August 10, 2020

Checkpoint Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights

GlobeNewswire August 5, 2020

LD Micro - Announces Preliminary List of Presenters for the LD-500

Accesswire August 5, 2020